Irbesartan And Hydrochlorothiazide Tablet
Product Images NDC 46708-444

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 46708-444). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Pack (Irbesartan 150125)

Label for Irbesartan and Hydrochlorothiazide Tablets, USP 150 mg / 12.5 mg oral tablets by Alembic Pharmaceuticals Limited. The label includes dosing information, storage instructions at 25°C with permitted excursions, and manufacturer details in Gujarat, India. Package contains 30 tablets with a barcode and space for lot and expiration dates.*

FDA Label Image

30's Bottle Pack (Irbesartan 300125)

Label for Irbesartan and Hydrochlorothiazide Tablets, USP, 300 mg/12.5 mg strength. Oral tablets supplied in a package of 30 by Alembic Pharmaceuticals Limited. Includes storage instructions, the NDC 46708-443-30, and manufacturer's address in Gujarat, India.*

FDA Label Image

30's Bottle Pack (Irbesartan 30025)

Label for Irbesartan and Hydrochlorothiazide Tablets, USP 300 mg/25 mg, oral tablets. The label includes dosage strength, NDC code 46708-444-30, manufacturer Alembic Pharmaceuticals Limited, a barcode, and storage instructions specifying controlled room temperature conditions. The label states Rx only and indicates a bottle of 30 tablets.*

FDA Label Image

Figure 1 And 2 (Irbesartanhctz Fig1 2)

A set of four line graphs showing probabilities of achieving specific systolic and diastolic blood pressure targets in patients from Initial Therapy Studies V (Week 8) and VI (Week 7). Each graph plots probability against baseline systolic or diastolic blood pressure, with multiple studies distinguished by line styles and colors. Figures include probabilities for SBP <140 mmHg, <130 mmHg, and DBP <90 mmHg, <80 mmHg.*

FDA Label Image

Structure (Irbesartanhctz Hctz)

Chemical structure diagram of the active ingredient Irbesartan, showing its molecular connectivity with atoms including sulfur, nitrogen, chlorine, and oxygen visible in the structure.*

FDA Label Image

Structure (Irbesartanhctz Irbe)

Chemical structure of the active ingredient Irbesartan, displayed as a 2D molecular diagram showing its characteristic rings and functional groups.*

FDA Label Image

Figure 3 And 4 (Irbesartanhctzi Fig3 4)

Two scatter plots with trend lines showing placebo-subtracted reductions in blood pressure parameters related to irbesartan dose in mg/day. The left graph (Figure 3) depicts reduction in trough systolic blood pressure (SeSBP) and the right graph (Figure 4) shows reduction in trough diastolic blood pressure (SeDBP) from an integrated analysis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.